Meadow Creek Wealth Advisors LLC Acquires 460 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Meadow Creek Wealth Advisors LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 26.2% during the 1st quarter, Holdings Channel reports. The firm owned 2,214 shares of the healthcare conglomerate’s stock after acquiring an additional 460 shares during the period. Meadow Creek Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $1,095,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Tealwood Asset Management Inc. lifted its holdings in shares of UnitedHealth Group by 0.4% in the 4th quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock worth $2,626,000 after acquiring an additional 19 shares during the last quarter. Atlas Private Wealth Advisors grew its position in UnitedHealth Group by 1.1% during the 4th quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock worth $923,000 after acquiring an additional 19 shares during the last quarter. Prentice Wealth Management LLC raised its holdings in UnitedHealth Group by 0.8% during the 4th quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock valued at $1,235,000 after buying an additional 19 shares during the last quarter. Baker Avenue Asset Management LP boosted its holdings in shares of UnitedHealth Group by 1.7% during the third quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock worth $615,000 after purchasing an additional 20 shares during the period. Finally, Granite Harbor Advisors Inc. grew its stake in UnitedHealth Group by 2.9% in the third quarter. Granite Harbor Advisors Inc. now owns 718 shares of the healthcare conglomerate’s stock worth $362,000 after purchasing an additional 20 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UNH stock opened at $489.90 on Thursday. The firm has a 50-day simple moving average of $498.64 and a two-hundred day simple moving average of $501.12. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The firm has a market cap of $450.90 billion, a price-to-earnings ratio of 29.94, a PEG ratio of 1.47 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the previous year, the company earned $6.26 earnings per share. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 27.55 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, June 17th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 dividend on an annualized basis and a yield of 1.71%. UnitedHealth Group’s dividend payout ratio (DPR) is 51.34%.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price objective on the stock in a research note on Wednesday, June 5th. Robert W. Baird started coverage on UnitedHealth Group in a research report on Thursday, May 30th. They set an “outperform” rating and a $597.00 price objective for the company. Morgan Stanley cut their target price on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Barclays upped their price target on shares of UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Finally, JPMorgan Chase & Co. lifted their target price on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a report on Thursday, May 30th. Three research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $579.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.